MedPage Today on MSN
Data Support First Approved Treatment for Acute Hepatitis C
The direct-acting antiviral glecaprevir/pibrentasvir (Mavyret) was highly effective and well tolerated in adults with acute ...
Pharmasset, Inc. has received fast-track designation from the U.S. Food and Drug Administration for R7128 for the treatment of chronic hepatitis C virus infection.Pharmasset, Inc. (Nasdaq: VRUS) has ...
Tapestry Health is a key partner in a new, $12-million Brown University five-year study of drug use and barriers to health care services, like HIV and hepatitis C treatment and overdose prevention.
(Reuters) - A trio of oral medicines from Abbott Laboratories Inc to treat hepatitis C produced unprecedented cure rates in patients who had failed to benefit from standard treatment, as well as very ...
In 2005, Nick Voyles was diagnosed with hepatitis C after being released from five years of incarceration. A nurse told him he had only six months to live. He was prescribed a drug cocktail, a ...
Breakthrough treatments introduced over the last decade have transformed hepatitis C from a chronic and potentially deadly infectious disease into one that can be cured. But these medications have ...
CHICAGO (Reuters) - Two standard treatments for hepatitis C work equally well at knocking down the virus for most patients, U.S. researchers reported on Wednesday. The findings, from a 3,000-patient ...
(CNN) — For a decade now, the world has had highly effective medications for hepatitis C infections. In the United States, they’ve mostly been sitting on the shelf, according to a new study. These ...
Medicare Part D or MAPD plans should cover hepatitis C medications, but the exact covered drugs depend on the plan. Infused drugs and other treatments are covered by Original Medicare (parts A and B) ...
WASHINGTON (AP) -- Shares of drugmaker Gilead Sciences Inc. hit an all-time high in trading Tuesday after the company released overwhelmingly positive results for an experimental hepatitis C drug that ...
Drugmaker Bristol-Myers Squibb Co. is suspending a midstage study of a potential hepatitis C treatment after at least one patient suffered heart failure. The New York company hasn't determined the ...
Ten years ago, safe and effective treatments for hepatitis C became available. These pills are easy-to-take oral antivirals with few side effects. They cure 95% of patients who take them. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results